Article Text

Download PDFPDF

Correspondence
Benzodiazepines and pneumonia or aspiration pneumonitis
Free
  1. Irene Campbell-Taylor
  1. Correspondence to Dr Irene Campbell-Taylor, 4303 New Waterford Highway, New Waterford NS B1H 2E1, Canada; drirenect{at}aol.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Dr Obiora et al 1 have presented some interesting data. One could quibble about the validity of the nested case-control model, but this issue is important mainly in identifying the fact that the patients were not individually assessed, nor were their particular variables, apart from the ones of interest, benzodiazepines and pneumonia, taken into consideration. Part of the randomness was accounted for by the use of conditional logistic regression but, as frequently happens, the authors appear not to have differentiated between pneumonitis and pneumonia, not surprisingly as they were dependent on diagnoses given by other physicians. These two terms are so frequently used as synonyms that it appears that few remember that they are very different entities.2 The authors mention the greater use of benzodiazepines in the elderly, and this is one group of greatest interest.3

Individuals at an advanced age, with diseases such as diabetes, Chronic Obstructive Pulmonary Disease, Parkinson disease and others, have a high incidence of gastroesophageal reflux (GER). Benzodiazepines are known to increase the risk of reflux being known, anecdotally, as ‘muscle relaxants’.4 ,5 The lower oesophageal sphincter is not a true sphincter but an area of muscle with, normally, increased tone. When this tone is diminished, reflux results, most often during the deepest part of sleep, and is likely to be unwitnessed. Unless there has been massive aspiration of stomach contents, the patient may simply feel unwell for a day or so, may have a fever and malaise, and 4–5 days later, develop a bacterial pneumonia due to the normal inhalation of saliva which uses the original area of chemical damage as a base for infection.6 ,7 It is suggested that the use of benzodiazepines be very carefully considered in individuals known to suffer GER, to suffer a disease in which GER is common, or one in which immunodeficiency may be inferred. This is not to imply that the benzodiazepines themselves affect immune status, but that infection is likely to be more hazardous in such patients as a result of the above.

References

View Abstract

Footnotes

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles

  • PostScript
    Robert D Sanders